Literature DB >> 9074575

Progression to dementia in patients with isolated memory loss.

J Bowen1, L Teri, W Kukull, W McCormick, S M McCurry, E B Larson.   

Abstract

BACKGROUND: The diagnosis of dementia requires both memory loss and at least one other type of cognitive impairment. The natural history of patients with severe memory loss but no other type of cognitive impairment is poorly understood. We studied progression to dementia in patients with isolated memory loss.
METHODS: From a registry of 811 patients with cognitive complaints, 21 patients with severe isolated memory loss of unknown cause were identified and followed up for a mean of 48 months. A comparison group of 198 patients on the same register was identified with newly recognised cognitive complaints but without dementia or isolated memory loss (mean follow-up 31 months). We did a range of neuropsychological tests at intake.
FINDINGS: During follow-up, 48% (n = 10) of patients with isolated memory loss-developed dementia compared with 18% (n = 36) of the comparison group. Life-table analysis showed the mean times to a diagnosis of dementia was 3.77 years (95% CI 2.99-4.56) and 5.96 years (5.60-6.31), respectively (p = 0.01). The neuropsychological tests did not predict which patients would progress to dementia.
INTERPRETATION: Patients with severe isolated memory loss have an increased risk of developing dementia and should be closely followed-up.

Entities:  

Mesh:

Year:  1997        PMID: 9074575     DOI: 10.1016/S0140-6736(96)08256-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  59 in total

1.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

2.  Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype.

Authors:  J Cervilla; M Prince; S Joels; S Lovestone; A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 3.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

4.  Astrocytic changes with aging and Alzheimer's disease-type pathology in chimpanzees.

Authors:  Emily L Munger; Melissa K Edler; William D Hopkins; John J Ely; Joseph M Erwin; Daniel P Perl; Elliott J Mufson; Patrick R Hof; Chet C Sherwood; Mary Ann Raghanti
Journal:  J Comp Neurol       Date:  2019-01-07       Impact factor: 3.215

5.  Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.

Authors:  T R Stoub; E J Rogalski; S Leurgans; D A Bennett; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2008-09-21       Impact factor: 4.673

6.  Linking hippocampal structure and function to memory performance in an aging population.

Authors:  Christiane Reitz; Adam M Brickman; Truman R Brown; Jennifer Manly; Charles DeCarli; Scott A Small; Richard Mayeux
Journal:  Arch Neurol       Date:  2009-11

7.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.

Authors:  J Tian; R S Bucks; J Haworth; G Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

8.  Neuropsychological characteristics of mild cognitive impairment subgroups.

Authors:  O L Lopez; J T Becker; W J Jagust; A Fitzpatrick; M C Carlson; S T DeKosky; J Breitner; C G Lyketsos; B Jones; C Kawas; L H Kuller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

9.  Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease.

Authors:  Milap A Nowrangi; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos; Kenichi Oishi; Marilyn Albert; Susumu Mori; Michelle M Mielke
Journal:  Alzheimers Dement       Date:  2012-12-12       Impact factor: 21.566

Review 10.  Proton MRS in mild cognitive impairment.

Authors:  Kejal Kantarci
Journal:  J Magn Reson Imaging       Date:  2013-04       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.